Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 report

por Suri, Rajinder Kumar, Liu, Christina, Marini, Aila
Publicado 2023

COVID-19 vaccine capacity: Challenges and mitigation – The DCVMN perspective

por Hayman, Benoit, Suri, Rajinder, Prasad, Sai D.
Publicado 2021

Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting

por Kumar Suri, Rajinder, Hayman, Benoit, Prasad, Sai D., Makhoana, Morena, Tippoo, Patrick
Publicado 2022

Accelerating research and development of new vaccines against tuberculosis: a global roadmap

por Cobelens, Frank, Suri, Rajinder Kumar, Helinski, Michelle, Makanga, Michael, Weinberg, Ana Lúcia, Schaffmeister, Britta, Deege, Frank, Hatherill, Mark
Publicado 2022

Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report

por Viviani, Laura, Reid, Kirsty, Gastineau, Thierry, Milne, Catherine, Smith, Dean, Levis, Robin, Lei, Dianliang, van Ooij, Mark, Gilbert, Philippe Alexandre, Vandeputte, Joris, Xie, Jianxun, Madhuri, Leena, Shaid, Shahjahan, Kubiak, Vaughn, Suri, Rajinder, Mizukami, Takuo, Shirasaki, Yoshihisa, Li, Xiantang, Zhou, Ying-Ying, Trapkova, Alla, Goel, Sunil, Prakash, Jai, Subagio, Amrullah Aninditio, Suwarni, Eniek, Jung, Kyung Jin, Sanyal, Gautam, Das, Pradip, Coppens, Emmanuelle, Wright, David, Peng, Zhechu, Northeved, Helle, Jungbäck, Carmen, Kirpitchenok, Tatiana, Del Pace, Lorenzo, Seo, Borami, Poojary, Brinda, Ottoni, Antoniana
Publicado 2022